ARTICLE | Emerging Company Profile
Satellite: cell therapy implants for any outpost in the body
Led by AveXis vet Lennon, Boston area biotech raises $110M with backing from series A lead aMoon to develop cell-based tissue therapies
April 20, 2022 11:58 AM UTC
Satellite is taking a platform-based approach to the delivery and engraftment of cell-based therapies to restore, repair or replace diseased tissues and organs.
Based on work from academic co-founders Sangeeta Bhatia and Arnav Chhabra at the Massachusetts Institute of Technology and Christopher Chen at Boston University, Satellite Bio Inc. is developing allogeneic cell therapies delivered via an implant known as the Satellite Adaptive Tissue platform...